Evidence map›Paper›PMID 36790492›Full record

ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2023

Changes in the clinical spectrum of pediatric moyamoya disease over 40 years.

Mai Fujioka, Shoko Hara, Maki Mukawa, Jun Karakama, Motoki Inaji, Yoji Tanaka, Tadashi Nariai, Taketoshi Maehara

Abstract read
PubMed Publisher
In one paragraph

Article in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mai FujiokaDepartment of Neurosurgery, Tokyo Medical and Dental University, Tokyo, Japan.
Shoko HaraDepartment of Neurosurgery, Tokyo Medical and Dental University, Tokyo, Japan. shara.nsrg@tmd.ac.jp.ORCID http://orcid.org/0000-0003-1097-2738
Maki MukawaDepartment of Neurosurgery, Tokyo Medical and Dental University, Tokyo, Japan.
Jun KarakamaDepartment of Neurosurgery, Tokyo Medical and Dental University, Tokyo, Japan.
Motoki InajiDepartment of Neurosurgery, Tokyo Medical and Dental University, Tokyo, Japan.ORCID http://orcid.org/0000-0002-6759-5729
Yoji TanakaDepartment of Neurosurgery, Tokyo Medical and Dental University, Tokyo, Japan.ORCID http://orcid.org/0000-0002-2433-924X
Tadashi NariaiDepartment of Neurosurgery, Tokyo Medical and Dental University, Tokyo, Japan.ORCID http://orcid.org/0000-0001-8819-4855
Taketoshi MaeharaDepartment of Neurosurgery, Tokyo Medical and Dental University, Tokyo, Japan.ORCID http://orcid.org/0000-0001-6804-4665

Funding

Japan Society for the Promotion of Science 19K18406
6 · The paper itself

Abstract

objectiveTo investigate the chronological changes in the clinical presentation and long-term prognosis of pediatric-onset moyamoya disease in our institute over 40 years.

methodsWe evaluated 282 pediatric-onset (≤ 15 years old) moyamoya disease patients who visited our institute from 1981 to 2020 (divided into the former period, 1981-2000, and the latter period, 2001-2020). Differences in the clinical presentation and the long-term outcome were compared between the periods. Multivariate analysis was also performed to reveal the risk factors for poor long-term outcomes.

resultsCompared to the former period, the total number of patients, the onset age and both the number of patients with family history and relatively older patients without symptoms or with headache were greater in the latter period (p < 0.05). The number of patients with poor long-term outcomes was significantly lower in the latter period (24.9% vs. 6.7%, p < 0.01). Multivariate analysis revealed that stroke onset, late cerebrovascular events and postoperative complications were independent risk factors for poor long-term outcomes (odds ratio = 31.4, 40.8 and 5.4, respectively).

conclusionsOver the last 40 years, the number of pediatric moyamoya disease patients has increased, especially in relatively older patients with mild presentation and favorable long-term outcomes. In clinical studies, these chronological changes and the inclusion period of the participants need to be accounted for. Whether the increased diagnostic rate in the recent era has led to a decrease in late cerebrovascular events and favorable outcomes throughout life remains unknown and should be evaluated in the future.

Indexed as

Moyamoya DiseaseAdolescentAdultAge of OnsetCerebrovascular DisordersChildFemaleFollow-Up StudiesHeadacheHumansMaleMiddle AgedPrognosisRisk FactorsStrokeTime FactorsMoyamoya diseaseOutcomePediatricPrognosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.